The cost effectiveness of buccolam® (midazolam oromucosal solution) for the treatment of prolonged, acute, convulsive seizures in the community setting in Spain

 

Publication Type:
Poster


Citation:

Lopez-Bastida J, Gil Aguirre A and Lee D. The cost effectiveness of buccolam® (midazolam oromucosal solution) for the treatment of prolonged, acute, convulsive seizures in the community setting in spain. 15th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress (ISPOR). Berlin, Germany. 3-7 November 2012. Poster PND41.

 


Link to publication ⟶

⟵ Back to Search Results